Similarly, IL-1β was found to be elevated in patients with coronary artery disease and heart failure, with studies by Gotsman et al. (2014) and Ridker et al. (2017) showing that IL-1β levels are predictive of worse outcomes in these populations [20,29]. This evidence concerns the gene IL1B and heart failure.